Leo Cancer Care and Mevion Medical Systems are entering a spearheading partnership that looks set to open up a bright new future for proton therapy treatment.

With smaller footprints for patient positioning and beam delivery units, the agreement between the companies means a proton therapy solution that will fit into an existing LINAC vault.

The smaller and more cost-effective solutions – with Leo Cancer Care’s innovative upright positioning system and CT scanner paired with Mevion’s smallest-in-the-world self-shielded proton accelerator and supported by RaySearch treatment planning capabilities– could bring a new lease of life to an industry challenged by the size and costs.

Watch Tina Yu, CEO of Mevion Medical Systems and Stephen Towe, CEO of Leo Cancer Care, discuss the new partnership and what it will mean for the proton therapy industry.

#partnership #collaboration #future #innovation #radiotherapy #protontherapy

*The MEVION S250-FIT Proton Therapy System with the Leo Cancer Care technology is not yet available for clinical use, pending regulatory approval

свернуть